News Focus
News Focus
icon url

madrose1

09/21/06 8:37 AM

#500575 RE: madrose1 #500560

Lifecell Corp-LIFC reiterate Buy following bus tour@NEED
Needham does not believe Bard (BCR) is getting traction with Collamend or Allomax in the initial launches and they expect LIFC to launch a xenograft, bringing possible upside to 2007 estimates. :